In vitro blood cell responsiveness to IFN-α predicts clinical response independently of IL28B in hepatitis C virus genotype 1 infected patients

BACKGROUND: Treatment with interferon-alpha (IFN-α) and ribavirin successfully clears hepatitis C virus (HCV) infection in 50% of patients infected with genotype 1. Addition of NS3-4A protease inhibitors (PIs) increases response rates but results in additional side effects and significant economic c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourke, Nollaig M, O’Neill, Mary-Teresa, Sarwar, Shahzad, Norris, Suzanne, Stewart, Stephen, Hegarty, John E, Stevenson, Nigel J, O’Farrelly, Cliona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112837/
https://www.ncbi.nlm.nih.gov/pubmed/25048205
http://dx.doi.org/10.1186/1479-5876-12-206

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112837/
https://www.ncbi.nlm.nih.gov/pubmed/25048205
http://dx.doi.org/10.1186/1479-5876-12-206

Ejemplares similares